Evaluation and Compararison of diagnostic and prognostic accuracy of different biomarkers like Procalcitonin, CD64, Group II phospholipase A 2 and Human neutrophil lipocalin for adult sepsis and septic shock in sick patients admitted in Emergency Department.

Comparative evaluation of diagnostic and prognostic accuracy of Procalcitonin, CD64, Group II phospholipase A 2 and Human neutrophil lipocalin for adult sepsis and septic shock patients admitted in Emergency Department. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/06/088741

Enrollment

118

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Control Intervention1: healthy volunteer: patient relatives

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age more than 18 years 2. sepsis according to sepsis 3 criteria. 3, emergency department

Exclusion criteria

Exclusion criteria: 1. Not giving consent for test. 2. Patients with immune-related diseases- can influence biomarker level.

Design outcomes

Primary

Measure	Time frame
The diagnostic accuracy of CD64, PLA 2GIIA, HML and Procalcitonin in sepsis and septic shock patients in emergency department. Timepoint: 1 year	—

Secondary

Measure	Time frame
any correlation between mortality with admission biomarker levels & admission SOFA score.Timepoint: 1 year	—

Countries

India

Contacts

Public ContactTanmoy Ghatak

SGPGI

tanmoyghatak@gmail.com09455037848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026